Antimicrobial peptide against multiresistant bacteria.

Antimicrobial peptide of the ceropin family against multiresistant bacteria.
Invention patent No. 13140269 Colombia (granted); invention patent NC2018/0009648 Colombia (granted) and invention patent NC2021/0008459 Colombia (under evaluation).
Biotechnology, Health
Medicine, biotechnology, pharmaceutical sector.
Based on new modified cecropins and peptides and recombinant production methods with antimicrobial activity especially against Gram-negative bacteria including multidrug-resistant bacteria, with low cytotoxicity activity.
  • Decreases hospital stay and mortality associated with Gram-negative bacteria Base active ingredient for the design of medical devices or treatments.
  • Active against bacterial strains resistant to conventional antibiotics.
  • Fast-acting drug.
  • Antimicrobial drug with multiple targets of action.
  • Antimicrobial drug with difficult acquisition of resistance.
Universidad del Quindío.